Option Care Health, Inc. (OPCH)
NASDAQ: OPCH · Real-Time Price · USD
27.65
+0.61 (2.26%)
At close: Nov 7, 2025, 4:00 PM EST
27.73
+0.08 (0.29%)
After-hours: Nov 7, 2025, 6:23 PM EST
Option Care Health Stock Forecast
Stock Price Forecast
The 8 analysts that cover Option Care Health stock have a consensus rating of "Buy" and an average price target of $34.88, which forecasts a 26.15% increase in the stock price over the next year. The lowest target is $27 and the highest is $41.
Price Target: $34.88 (+26.15%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Option Care Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Buy | 3 | 3 | 3 | 3 | 4 | 4 |
| Hold | 1 | 1 | 1 | 1 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 9 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Hold Maintains $30 → $27 | Hold | Maintains | $30 → $27 | -2.35% | Nov 3, 2025 |
| Citizens | Citizens | Buy Maintains $38 → $36 | Buy | Maintains | $38 → $36 | +30.20% | Oct 31, 2025 |
| Barrington Research | Barrington Research | Buy Maintains $38 | Buy | Maintains | $38 | +37.43% | Oct 31, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $35 | Buy | Initiates | $35 | +26.58% | Oct 17, 2025 |
| TD Cowen | TD Cowen | Hold Initiates $30 | Hold | Initiates | $30 | +8.50% | Oct 2, 2025 |
Financial Forecast
Revenue This Year
5.75B
from 5.00B
Increased by 14.96%
Revenue Next Year
6.19B
from 5.75B
Increased by 7.74%
EPS This Year
1.75
from 1.23
Increased by 42.14%
EPS Next Year
1.89
from 1.75
Increased by 8.23%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 5.9B | 6.5B | |||
| Avg | 5.7B | 6.2B | |||
| Low | 5.5B | 5.8B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 18.6% | 12.9% | |||
| Avg | 15.0% | 7.7% | |||
| Low | 9.7% | 1.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.83 | 2.12 | |||
| Avg | 1.75 | 1.89 | |||
| Low | 1.65 | 1.50 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 48.5% | 21.3% | |||
| Avg | 42.1% | 8.2% | |||
| Low | 33.9% | -14.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.